Key Insights

Highlights

Treatment Research

1 treatments under study, led by Samples

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05463796Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Samples1

Active Sponsors

  • Dana-Farber Cancer Institute1

Top Investigators

Related Conditions

  • Benign Bone Lesions With Risk Of Malignant Degeneration1
  • Highgrade Bladder Urothelial Dysplasiacarcinoma In Situ1
  • Barrett Esophagus1
  • High Grade Prostatic Epithelial Neoplasia1
  • Cancer Predisposition Syndrome1

Activity Timeline